The development of a rhinovirus (RV)-RNA-specific reverse transcription (RT
)-PCR assay is complicated by the close homology between the RV and enterov
irus (EV) genomes in the highly conserved 5'-noncoding region, which is cho
sen for primer design in most RT-PCR assays. We have developed a sensitive,
rapid, and RV-specific nested RT-PCR assay and have used it to test nasoph
aryngeal aspirates from 556 patients presenting with acute respiratory trac
t infections. RV RNA was detected by nested RT-PCR not only in all of 52 sa
mples that were RV positive by virus isolation methods but also in 124 of 3
67 samples that were negative by virus isolation methods and enzyme-linked
immunosorbent assay (ELISA). In addition, in 23 of 137 samples that were po
sitive for a different respiratory virus by virus isolation and/or ELISA, R
V RNA was detected by RT-PCR. EVs, adenoviruses, respiratory syncytial viru
ses, coronaviruses, and influenza and parainfluenza viruses, including clin
ical isolates as well as stock viruses, were not amplified in our RV-specif
ic RT-PCR assay, indicating that this assay was highly specific. The proces
sing time was less than 2 days for the RT-PCR, as opposed to up to 2 weeks
for virus isolation. These results indicate that nested RT-PCR is more sens
itive than conventional methods for the detection of RV in patients experie
ncing acute respiratory tract infections and represents the only reliable t
ool for the early laboratory diagnosis of RV infections. This is especially
important in light of new opportunities for therapy currently being develo
ped.